NO20031771D0 - Nye derivater av cyanoaryl(eller cyanoheteroaryl)-karbonyl- piperazinylpyrimidiner, deres fremstilling og anvendelse som medikament - Google Patents
Nye derivater av cyanoaryl(eller cyanoheteroaryl)-karbonyl- piperazinylpyrimidiner, deres fremstilling og anvendelse som medikamentInfo
- Publication number
- NO20031771D0 NO20031771D0 NO20031771A NO20031771A NO20031771D0 NO 20031771 D0 NO20031771 D0 NO 20031771D0 NO 20031771 A NO20031771 A NO 20031771A NO 20031771 A NO20031771 A NO 20031771A NO 20031771 D0 NO20031771 D0 NO 20031771D0
- Authority
- NO
- Norway
- Prior art keywords
- carbonylpiperazinylpyrimidines
- cyanoheteroaryl
- cyanoaryl
- drug
- preparation
- Prior art date
Links
- RLYTYKUXGBXMRJ-UHFFFAOYSA-N C(=O)=C1N(CCNC1)C1=NC=CC=N1 Chemical class C(=O)=C1N(CCNC1)C1=NC=CC=N1 RLYTYKUXGBXMRJ-UHFFFAOYSA-N 0.000 title 1
- 125000002944 cyanoaryl group Chemical group 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200002532A ES2167276B1 (es) | 2000-10-20 | 2000-10-20 | Nuevos derivados de cianoaril (o cianoheteroaril)-carbonil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
| PCT/ES2001/000378 WO2002032880A1 (es) | 2000-10-20 | 2001-10-10 | Nuevos derivados de cianoaril (o cianoheteroaril)-carbonil-piperazinil-pirimidinas, su preparación y su aplicación como medicamentos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20031771D0 true NO20031771D0 (no) | 2003-04-16 |
| NO20031771L NO20031771L (no) | 2003-06-06 |
Family
ID=8495344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20031771A NO20031771L (no) | 2000-10-20 | 2003-04-16 | Nye derivater av cyanoaryl(eller cyanoheteroaryl)-karbonyl- piperazinylpyrimidiner, deres fremstilling og anvendelse som medikament |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7300937B2 (no) |
| EP (1) | EP1327630B1 (no) |
| JP (1) | JP2004511550A (no) |
| KR (1) | KR20030037687A (no) |
| CN (1) | CN1221536C (no) |
| AR (1) | AR030885A1 (no) |
| AT (1) | ATE380795T1 (no) |
| AU (2) | AU9387701A (no) |
| BR (1) | BR0114999A (no) |
| CA (1) | CA2426097A1 (no) |
| CZ (1) | CZ20031116A3 (no) |
| DE (1) | DE60131873T2 (no) |
| ES (2) | ES2167276B1 (no) |
| HU (1) | HUP0302901A3 (no) |
| IL (1) | IL155259A0 (no) |
| MX (1) | MXPA03003348A (no) |
| NO (1) | NO20031771L (no) |
| NZ (1) | NZ525246A (no) |
| PL (1) | PL361033A1 (no) |
| PT (1) | PT1327630E (no) |
| RU (1) | RU2259358C2 (no) |
| TW (1) | TWI220144B (no) |
| WO (1) | WO2002032880A1 (no) |
| ZA (1) | ZA200302452B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003218737B2 (en) * | 2002-03-13 | 2008-04-10 | Janssen Pharmaceutica N.V. | Inhibitors of histone deacetylase |
| CN103360343B (zh) * | 2012-03-30 | 2017-04-19 | 凯惠药业(上海)有限公司 | 一种哌嗪酰胺类化合物的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2535718A1 (fr) * | 1982-11-09 | 1984-05-11 | Sanofi Sa | (piperazinyl-1)-2 pyrimidines, leurs sels, procede pour leur preparation et compositions pharmaceutiques en contenant |
| US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
| US4668687A (en) * | 1984-07-23 | 1987-05-26 | Bristol-Myers Company | Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones |
| FR2642759B1 (fr) * | 1989-02-09 | 1991-05-17 | Laboratorios Esteve Sa | Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante |
| FR2654621B1 (fr) * | 1989-11-22 | 1994-09-23 | Esteve Labor Dr | Inhibition du syndrome d'abstinence. |
| FR2672052B1 (fr) * | 1991-01-28 | 1995-05-24 | Esteve Labor Dr | Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments. |
| JPH04202185A (ja) * | 1990-11-30 | 1992-07-22 | Terumo Corp | ピペラジン誘導体及びこれを含有する医薬製剤 |
| FR2701260B1 (fr) * | 1993-02-05 | 1995-05-05 | Esteve Labor Dr | Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments. |
| ES2125206B1 (es) * | 1997-07-21 | 1999-11-16 | Esteve Labor Dr | Derivados de acil-piperazinil-pirimidinas, su preparacion y su aplicacion como medicamentos. |
-
2000
- 2000-10-20 ES ES200002532A patent/ES2167276B1/es not_active Expired - Fee Related
-
2001
- 2001-10-10 WO PCT/ES2001/000378 patent/WO2002032880A1/es not_active Ceased
- 2001-10-10 AU AU9387701A patent/AU9387701A/xx active Pending
- 2001-10-10 PL PL01361033A patent/PL361033A1/xx not_active Application Discontinuation
- 2001-10-10 AT AT01974344T patent/ATE380795T1/de not_active IP Right Cessation
- 2001-10-10 CA CA002426097A patent/CA2426097A1/en not_active Abandoned
- 2001-10-10 BR BR0114999-7A patent/BR0114999A/pt not_active IP Right Cessation
- 2001-10-10 AU AU2001293877A patent/AU2001293877B2/en not_active Ceased
- 2001-10-10 HU HU0302901A patent/HUP0302901A3/hu unknown
- 2001-10-10 MX MXPA03003348A patent/MXPA03003348A/es active IP Right Grant
- 2001-10-10 CN CNB018176291A patent/CN1221536C/zh not_active Expired - Fee Related
- 2001-10-10 NZ NZ525246A patent/NZ525246A/en unknown
- 2001-10-10 DE DE60131873T patent/DE60131873T2/de not_active Expired - Lifetime
- 2001-10-10 EP EP01974344A patent/EP1327630B1/en not_active Expired - Lifetime
- 2001-10-10 US US10/312,195 patent/US7300937B2/en not_active Expired - Fee Related
- 2001-10-10 IL IL15525901A patent/IL155259A0/xx unknown
- 2001-10-10 CZ CZ20031116A patent/CZ20031116A3/cs unknown
- 2001-10-10 PT PT01974344T patent/PT1327630E/pt unknown
- 2001-10-10 ES ES01974344T patent/ES2296806T3/es not_active Expired - Lifetime
- 2001-10-10 JP JP2002536263A patent/JP2004511550A/ja active Pending
- 2001-10-10 RU RU2003114437/04A patent/RU2259358C2/ru not_active IP Right Cessation
- 2001-10-10 KR KR10-2003-7005303A patent/KR20030037687A/ko not_active Abandoned
- 2001-10-12 AR ARP010104819A patent/AR030885A1/es unknown
- 2001-10-17 TW TW090125627A patent/TWI220144B/zh not_active IP Right Cessation
-
2003
- 2003-03-28 ZA ZA200302452A patent/ZA200302452B/en unknown
- 2003-04-16 NO NO20031771A patent/NO20031771L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL155259A0 (en) | 2003-11-23 |
| US20040048872A1 (en) | 2004-03-11 |
| HUP0302901A2 (hu) | 2004-03-01 |
| EP1327630B1 (en) | 2007-12-12 |
| NO20031771L (no) | 2003-06-06 |
| WO2002032880A1 (es) | 2002-04-25 |
| BR0114999A (pt) | 2004-02-03 |
| PT1327630E (pt) | 2008-03-05 |
| HK1060358A1 (en) | 2004-08-06 |
| NZ525246A (en) | 2004-11-26 |
| HUP0302901A3 (en) | 2004-04-28 |
| MXPA03003348A (es) | 2003-06-19 |
| TWI220144B (en) | 2004-08-11 |
| CA2426097A1 (en) | 2003-04-16 |
| RU2259358C2 (ru) | 2005-08-27 |
| US7300937B2 (en) | 2007-11-27 |
| AU9387701A (en) | 2002-04-29 |
| DE60131873D1 (de) | 2008-01-24 |
| ES2167276B1 (es) | 2003-04-01 |
| AR030885A1 (es) | 2003-09-03 |
| PL361033A1 (en) | 2004-09-20 |
| KR20030037687A (ko) | 2003-05-14 |
| JP2004511550A (ja) | 2004-04-15 |
| CN1221536C (zh) | 2005-10-05 |
| DE60131873T2 (de) | 2008-12-04 |
| CN1469866A (zh) | 2004-01-21 |
| EP1327630A1 (en) | 2003-07-16 |
| ES2167276A1 (es) | 2002-05-01 |
| ES2296806T3 (es) | 2008-05-01 |
| AU2001293877B2 (en) | 2007-01-04 |
| ZA200302452B (en) | 2004-03-29 |
| CZ20031116A3 (cs) | 2003-10-15 |
| ATE380795T1 (de) | 2007-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20024176L (no) | Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling | |
| NO20030302L (no) | Nye heteroarylderivater og deres anvendelse som medikamenter | |
| NO20030298D0 (no) | Nye heteroarylderivater og deres anvendelse som farmasöytiske midler | |
| DK1368349T3 (da) | Xanthinderivater, deres fremstilling og deres anvendelse som lægemidler | |
| NO20015113D0 (no) | Nye forbindelser, deres fremstilling og anvendelse | |
| NO20035298D0 (no) | CDK-inhiberende pyrimider, deres fremstilling og deres anvendelse som legemidler | |
| NO20040680D0 (no) | Nye dihydropterinonerfremgangsmate for fremstilling derav og deres anvendelse som legemiddel | |
| NO20020811D0 (no) | Sulfonylkarboksamidderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
| DK1445252T3 (da) | Sulfonamid-derivater, deres fremstilling og anvendelse som medikamenter | |
| DK1294682T3 (da) | Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel | |
| NO20024175L (no) | Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene | |
| NO20006029D0 (no) | Pyrazolinderivater, deres fremstilling og anvendelse som legemidler | |
| NO20040356L (no) | Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling. | |
| NO20025029D0 (no) | Nye epotilonderivater, fremgangsmåte for fremstilling derav og deres farmasöytiske anvendelse | |
| NO20000294L (no) | Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler | |
| DK1095025T3 (da) | Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler | |
| NO20042635L (no) | 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin | |
| DK1230230T3 (da) | Derivater af indeno-dihydrothiazol, fremstilling deraf og anvendelse som anorektiske lægemidler | |
| DK1246807T3 (da) | Hydantoin-, thiohydantoin-, purimidindion- og thioxopyrimidinonderivater, fremgangsmåder til deres fremstilling og deres anvendelse som lægemidler | |
| DK1004592T3 (da) | Nye erythromycinderivater, deres fremstilling og deres anvendelse som medikamenter | |
| NO20023146L (no) | Substituerte fenyl-piperazinderivater, deres fremstilling og anvendelse | |
| NO20026154L (no) | Nye substituerte ftalider, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger inneholdende dem | |
| NO20032234L (no) | Nye imidazolderivater, deres fremstilling og anvendelse | |
| NO20030382L (no) | Nye indolderivater og deres anvendelse som medikamenter | |
| NO20052124D0 (no) | Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |